2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine

Metabolite details

Identifier

CBQVLMCHMFGPMX-RGURZIINSA-O

InChI Key

CBQVLMCHMFGPMX-RGURZIINSA-O

IUPAC name

[3-[5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl]-1-carboxypropyl]-trimethylazanium

Preferred name

2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine

INN name

—

Synonym

—

ChEBI

CHEBI:174161

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day